NCR1 Produits
(Natural Cytotoxicity Triggering Receptor 1 (NCR1))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories NCR1 en vedette
NCR1 Anticorps
High quality antibodies with extensive validation data.
NCR1 Kits ELISA
Reliable ELISA kits for a wide range of species.
NCR1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
NCR1 recommandé Anticorps
- (3)
- (3)
- (4)
- (3)
NCR1 recommandé Kits ELISA
- (1)
NCR1 recommandé Protéines
- (4)
- (3)
- (3)
Dernières publications sur nos produits NCR1
: "Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice." dans: Cellular and molecular gastroenterology and hepatology, Vol. 7, Issue 1, pp. 115-134, (2019) (PubMed).: "Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells." dans: Biological & pharmaceutical bulletin, Vol. 42, Issue 1, pp. 57-65, (2019) (PubMed).
: "NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 200, Issue 11, pp. 3762-3768, (2018) (PubMed).
: "Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment." dans: Oncotarget, Vol. 9, Issue 47, pp. 28364-28378, (2018) (PubMed).
: "Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer." dans: Molecular cancer therapeutics, Vol. 17, Issue 10, pp. 2079-2090, (2018) (PubMed).
: "Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization." dans: Nature cell biology, Vol. 20, Issue 8, pp. 966-978, (2018) (PubMed).
: "Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey." dans: Oncotarget, Vol. 9, Issue 55, pp. 30527-30538, (2018) (PubMed).
: "Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 198, Issue 7, pp. 2589-2601, (2017) (PubMed).
: "NK cell heparanase controls tumor invasion and immune surveillance." dans: The Journal of clinical investigation, Vol. 127, Issue 7, pp. 2777-2788, (2017) (PubMed).
: "Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma." dans: Molecular therapy oncolytics, Vol. 5, pp. 87-96, (2017) (PubMed).
Synonymes et noms alternatifs relatifs à NCR1
natural cytotoxicity triggering receptor 1 (NCR1), natural cytotoxicity triggering receptor 1 (Ncr1), CD335, KILR-1, LY94, Ly94, NK-p46, Nk-p46, NKP46, NKp46, Nkp46Protein level used designations for NCR1
- NK cell-activating receptor
- lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46)
- natural killer cell p46-related protein
- MAR1 (mouse activating receptor 1)
- NK-p46
- activating receptor 1
- lymphocyte antigen 94
- mAR-1
- mNKp46
- NK receptor KILR-1
- NK-p46)
- NKACTR
- lymphocyte antigen 94 homolog (activating NK-receptor
- rAR-1
- rat-activating receptor 1